ABSTRACT
BackgroundWastewater surveillance is an effective approach to monitor population health, as exemplified by its role throughout the COVID-19 pandemic.AimThis study explores the possibility of extending wastewater surveillance to the Paris 2024 Olympic and Paralympic Games, focusing on identifying priority pathogen targets that are relevant and feasible to monitor in wastewater for these events.MethodsA list of 60 pathogens of interest for general public health surveillance for the Games was compiled. Each pathogen was evaluated against three inclusion criteria: (A) analytical feasibility; (B) relevance, i.e. with regards to the specificities of the event and the characteristics of the pathogen; and (C) added value to inform public health decision-making. Analytical feasibility was assessed through evidence from peer-reviewed publications demonstrating the detectability of pathogens in sewage, refining the initial list to 25 pathogens. Criteria B and C were evaluated via expert opinion using the Delphi method. The panel consisting of some 30 experts proposed five additional pathogens meeting criterion A, totalling 30 pathogens assessed throughout the three-round iterative questionnaire. Pathogens failing to reach 70% group consensus threshold underwent further deliberation by a subgroup of experts.ResultsSix priority targets suitable for wastewater surveillance during the Games were successfully identified: poliovirus, influenza A virus, influenza B virus, mpox virus, SARS-CoV-2 and measles virus.ConclusionThis study introduced a model framework for identifying context-specific wastewater surveillance targets for a mass gathering. Successful implementation of a wastewater surveillance plan for Paris 2024 could incentivise similar monitoring efforts for other mass gatherings globally.
Subject(s)
COVID-19 , SARS-CoV-2 , Wastewater , Humans , Wastewater/virology , Wastewater/microbiology , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19/transmission , SARS-CoV-2/isolation & purification , France/epidemiology , Sports , Public Health , Pandemics , Sewage/virology , Paris/epidemiology , Anniversaries and Special Events , Public Health Surveillance/methodsABSTRACT
The French National Reference Centre for Escherichia coli, Shigella and Salmonella (FNRC-ESS) detected two human clusters of 33 cases (median age: 10â¯years; 17 females) infected by Salmonella enterica serotype Bovismorbificans, ST142, HC5_243255 (EnteroBase HierCCcgMLST scheme) in September-November 2020 and of 11 cases (median age: 11â¯years; seven males) infected by S.â¯enterica serotype 4,12:i:-, ST34, HC5_198125 in October-December 2020. Epidemiological investigations conducted by Santé publique France linked these outbreaks to the consumption of dried pork sausages from the same manufacturer. S.â¯Bovismorbificans and S.â¯4,12:i:- were isolated by the National Reference Laboratory from different food samples, but both strains were identified in a single food sample only by qPCR. Three recalls and withdrawals of dried pork products were issued by the French general directorate of food of the French ministry for agriculture and food in November 2020, affecting eight supermarket chains. A notification on the European Rapid Alert System for Food and Feed and a European urgent enquiry on the Epidemic Intelligence Information System for Food and Waterborne Diseases and Zoonoses (EPIS-FWD) were launched. No cases were reported outside France. Outbreaks caused by multiple serotypes of Salmonella may go undetected by protocols in standard procedures in microbiology laboratories.
Subject(s)
Meat Products , Pork Meat , Red Meat , Salmonella Food Poisoning , Animals , Female , Male , Humans , Swine , Child , Salmonella typhimurium/genetics , Serogroup , Salmonella Food Poisoning/epidemiology , Salmonella Food Poisoning/microbiology , Red Meat/microbiology , France/epidemiology , Disease OutbreaksABSTRACT
A cluster of three confirmed autochthonous dengue cases was detected in October 2023 in the Val-de-Marne department neighbouring Paris, France. This marks the northernmost transmission of dengue in Europe reported to date. The epidemiological and microbiological investigations and the vector control measures are described. This event confirms the need for early case detection and response to contain dengue in Europe, especially given the 2024 Summer Olympic and Paralympic Games, when millions of visitors will visit the Greater Paris area.
Subject(s)
Aedes , Dengue , Sports , Humans , Animals , Paris/epidemiology , Dengue/diagnosis , Dengue/epidemiology , Dengue/prevention & control , France/epidemiology , Europe/epidemiology , Disease Outbreaks/prevention & controlABSTRACT
BackgroundDengue is a disease with major impacts on public health in tropical and subtropical countries. In Europe, in the past decade, few autochthonous outbreaks were described.AimWe aimed to identify factors associated with frequency of dengue virus infection among European travellers and at assessing how surveillance data could support preparedness against autochthonous outbreaks within Europe.MethodsWe performed a descriptive analysis of travel-related dengue cases reported by European countries from 2015 through 2019. Using flight passenger data, we calculated travellers' infection rates (TIR). We investigated the following associations: (i) between TIR and incidence rate in selected countries of infection and (ii) between number of travel-related cases and occurrence of autochthonous outbreaks within Europe.ResultsThere were 11,478 travel-related dengue cases and the TIR was 2.8 cases per 100,000 travellers. Most cases were infected in Asia (71%), predominantly in south-eastern Asia. The TIR was highest among travellers returning from Asia (6.1/100,000). There was an association between the incidence rate in the country of infection and the TIR but no association between the number of travel-related cases and occurrence of autochthonous outbreaks in Europe.ConclusionsThe likelihood of infection in travellers is a function of the ongoing epidemiological situation in the country of exposure. The number of travel-related cases alone is not sufficient to estimate the likelihood of autochthonous outbreaks where vectors are present in Europe. Additional contributing factors such as adequate vectorial capacity and suitable environmental conditions are required.
Subject(s)
Dengue , Travel , Dengue/epidemiology , Disease Outbreaks , Europe/epidemiology , Humans , Travel-Related IllnessABSTRACT
Autochthonous outbreaks of chikungunya have occurred in the European Union (EU) after virus introduction by infected travelers. We reviewed the surveillance data of travel-related cases reported in the EU during 2012-2018 to document factors associated with increased infection rates among travelers and to assess how surveillance data could support preparedness against secondary transmission and timely control of outbreaks. Thirteen EU countries reported 2,616 travel-related chikungunya cases. We observed 3 successive epidemiologic periods; the highest number of cases (75%) occurred during 2014-2015, when most cases were associated with the Caribbean and South America. The highest infection rates among travelers were observed during the same phase. Although surveillance of travel-related cases is relevant for estimating the infection risk for travelers, we could not identify a relationship between the number of infected travelers and a higher likelihood of secondary transmission in the EU.
Subject(s)
Chikungunya Fever , Chikungunya virus , Caribbean Region , Chikungunya Fever/epidemiology , European Union , Humans , South America , Travel , Travel-Related IllnessABSTRACT
On 27 December 2019, the French Public Health Agency identified a large increase in the number of acute gastroenteritis and vomiting visits, both in emergency departments and in emergency general practitioners' associations providing house-calls. In parallel, on 26 and 27 December, an unusual number of food-borne events suspected to be linked to the consumption of raw shellfish were reported through the mandatory reporting surveillance system. This paper describes these concomitant outbreaks and the investigations' results.
Subject(s)
Disease Outbreaks/statistics & numerical data , Emergency Service, Hospital/statistics & numerical data , Foodborne Diseases/virology , Gastroenteritis/epidemiology , Population Surveillance/methods , Sentinel Surveillance , Shellfish/virology , Vomiting/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Feces/virology , Female , Food Contamination , Foodborne Diseases/epidemiology , France/epidemiology , Humans , Male , Mandatory Reporting , Middle Aged , Norovirus/genetics , Norovirus/isolation & purification , Ostreidae/virology , Public Health , Vomiting/epidemiology , Young AdultABSTRACT
BACKGROUND: In a context of increasing use of Nucleic Acid Amplification Test, diagnoses of Neisseria gonorrhoeae and Chlamydia trachomatis infections among men increased in Europe and USA since 2007. We aimed to describe trends in the incidence of male urethritis in France between 2007 and 2017. METHODS: We analysed male urethritis clinical cases reported by the French GPs' Sentinelles network. RESULTS: GPs reported 1944 cases of male urethritis during the study period. The estimated annual incidence rates in men aged 15 years and older remained stable between 226 cases per 100,000 seen in 2007 and 196 in 2017 (P value = 0.9). A third-generation cephalosporin with macrolide or tetracycline was prescribed in 17.5% of cases in 2009 (27/154) and 32.4% in 2017 (47/145) (P value = 0.0327). CONCLUSIONS: The incidence rates for adult male urethritis diagnosed in primary care have remained stable since 2007 in France in contrast with the increasing trend of Neisseria gonorrhoeae and Chlamydia trachomatis infections based on microbiological surveillance. Using stable clinical definition for male urethritis seems essential to follow correctly epidemiological dynamic.
Subject(s)
Chlamydia trachomatis/genetics , Neisseria gonorrhoeae/genetics , Trichomonas vaginalis/genetics , Urethritis/diagnosis , Adolescent , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Cephalosporins/therapeutic use , Chlamydia trachomatis/isolation & purification , DNA, Bacterial/isolation & purification , DNA, Bacterial/metabolism , France/epidemiology , Humans , Incidence , Male , Middle Aged , Neisseria gonorrhoeae/isolation & purification , Nucleic Acid Amplification Techniques , Trichomonas vaginalis/isolation & purification , Urethritis/drug therapy , Urethritis/epidemiology , Urethritis/microbiology , Young AdultABSTRACT
Diagnoses of bacterial sexually transmitted infections (STI) have been increasing in France since their resurgence in the late 1990s. This article presents recent epidemiological trends until 2016 and the patients' characteristics. STI surveillance relies on sentinel networks: a clinician-based network RésIST (clinical, biological and behavioural data for early syphilis and gonorrhoea), the lymphogranuloma venereum (LGV) network (clinical, biological and behavioural data for rectal LGV, and the laboratory networks Rénachla and Rénago (demographic and biological data for chlamydial infections and gonorrhoea, respectively). Here we describe trends between 2014 and 2016, using data from diagnostic centres which participated regularly during the study period. The number of early syphilis, gonorrhoea and LGV diagnoses increased between 2014 and 2016, particularly in men who have sex with men. An increase in syphilis and gonorrhoea cases was also observed in heterosexuals. Nevertheless, we observed a drop in 2016 for syphilis and chlamydial infections after two decades of increases. Under-reporting and shortage of benzathine penicillin in 2016 may explain this latest evolution. Regular screening of patients and partners, followed by prompt treatment, remains essential to interrupt STI transmission in a context where human immunodeficiency virus (HIV) prevention has expanded towards biomedical prophylaxis.
Subject(s)
Heterosexuality/statistics & numerical data , Homosexuality, Male/statistics & numerical data , Mass Screening/methods , Population Surveillance/methods , Sexually Transmitted Diseases, Bacterial/epidemiology , Adult , Female , France/epidemiology , Gonorrhea/diagnosis , Gonorrhea/epidemiology , Humans , Lymphogranuloma Venereum/diagnosis , Lymphogranuloma Venereum/epidemiology , Male , Sentinel Surveillance , Sexually Transmitted Diseases, Bacterial/diagnosis , Syphilis/diagnosis , Syphilis/epidemiologyABSTRACT
On 1 October 2019, a locally-acquired Zika virus disease case was laboratory confirmed in Hyères, Var department. Active case finding identified two additional locally-acquired cases living within 90 m, with symptom onset 8 days before the index case. Extensive patient interviews did not yield information supporting transmission through sexual contact or substances of human origin. Vector-borne transmission by local Aedes albopictus mosquitoes is the most likely mode of transmission. Here we describe the public health response.
Subject(s)
Aedes/virology , Mosquito Vectors/virology , Saliva/virology , Zika Virus Infection/diagnosis , Zika Virus Infection/transmission , Zika Virus/isolation & purification , Animals , France , Humans , Mosquito Control/methods , Zika Virus Infection/virologyABSTRACT
On 1 December 2017, an outbreak of Salmonella Agona infections among infants was identified in France. To date, 37 cases (median age: 4 months) and two further international cases have been confirmed. Five different infant milk products manufactured at one facility were implicated. On 2 and 10 December, the company recalled the implicated products; on 22 December, all products processed at the facility since February 2017. Trace-forward investigations indicated product distribution to 66 countries.
Subject(s)
Disease Outbreaks/statistics & numerical data , Food Contamination/statistics & numerical data , Milk/microbiology , Salmonella Food Poisoning/epidemiology , Salmonella Infections/epidemiology , Salmonella/isolation & purification , Animals , Cattle , Electrophoresis, Gel, Pulsed-Field , Female , Food Microbiology , France/epidemiology , Humans , Incidence , Infant , Male , Salmonella/classification , Salmonella/genetics , Salmonella Food Poisoning/microbiology , Salmonella Infections/microbiology , SerotypingABSTRACT
Estimates of the annual numbers of foodborne illnesses and associated hospitalizations and deaths are needed to set priorities for surveillance, prevention, and control strategies. The objective of this study was to determine such estimates for 2008-2013 in France. We considered 15 major foodborne pathogens (10 bacteria, 3 viruses, and 2 parasites) and estimated that each year, the pathogens accounted for 1.28-2.23 million illnesses, 16,500-20,800 hospitalizations, and 250 deaths. Campylobacter spp., nontyphoidal Salmonella spp., and norovirus accounted for >70% of all foodborne pathogen-associated illnesses and hospitalizations; nontyphoidal Salmonella spp. and Listeria monocytogenes were the main causes of foodborne pathogen-associated deaths; and hepatitis E virus appeared to be a previously unrecognized foodborne pathogen causing ≈68,000 illnesses in France every year. The substantial annual numbers of foodborne illnesses and associated hospitalizations and deaths in France highlight the need for food-safety policymakers to prioritize foodborne disease prevention and control strategies.
Subject(s)
Bacterial Infections/epidemiology , Food Microbiology , Foodborne Diseases/epidemiology , Hospitalization/statistics & numerical data , Virus Diseases/epidemiology , Bacterial Infections/mortality , Campylobacter/isolation & purification , Campylobacter/pathogenicity , Food Safety , Foodborne Diseases/mortality , France/epidemiology , Hepatitis E virus/isolation & purification , Hepatitis E virus/pathogenicity , Humans , Listeria monocytogenes/isolation & purification , Listeria monocytogenes/pathogenicity , Norovirus/isolation & purification , Norovirus/pathogenicity , Public Health Surveillance , Salmonella/isolation & purification , Salmonella/pathogenicity , Survival Analysis , Virus Diseases/mortalityABSTRACT
Using samples from oysters clearly implicated in human disease, we quantified norovirus levels by using digital PCR. Concentrations varied from 43 to 1,170 RNA copies/oyster. The analysis of frozen samples from the production area showed the presence of norovirus 2 weeks before consumption.
Subject(s)
Caliciviridae Infections/epidemiology , Caliciviridae Infections/virology , Disease Outbreaks , Gastroenteritis/epidemiology , Gastroenteritis/virology , Norovirus/genetics , Ostreidae/virology , Animals , Food Contamination , Food Safety , Foodborne Diseases/epidemiology , Foodborne Diseases/virology , France/epidemiology , Genotype , Humans , Norovirus/classification , Norovirus/isolation & purification , RNA, ViralABSTRACT
Two extended-spectrum cephalosporin-resistant Neisseria gonorrhoeae isolates were discovered among 6,340 (0.03%) French isolates between 2010 and 2014. One isolate corresponded to the F89 multidrug-resistant N. gonorrhoeae isolate harboring a penA mosaic; whole-genome sequencing highlighted an additional R251H substitution in the ftsX gene recently involved in cephalosporin resistance. The other, ceftriaxone-resistant isolate (MIC, 0.25 mg/liter) harbored the PBP2 pattern XXXVI plus a P551S substitution and belonged to sequence type ST1579 (multilocus sequence typing [MLST]).
Subject(s)
Ceftriaxone/pharmacology , Cephalosporin Resistance/genetics , Neisseria gonorrhoeae/drug effects , Neisseria gonorrhoeae/genetics , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Cefixime/pharmacology , Cell Cycle Proteins/genetics , France , Genome, Bacterial , Humans , Microbial Sensitivity Tests , Multilocus Sequence Typing , Mutation , Neisseria gonorrhoeae/isolation & purificationABSTRACT
A prolonged outbreak of Salmonella enterica serotype Enteritidis occurred in northern France between December 2014 and April 2015. Epidemiological investigations following the initial notification on 30 December 2014 of five cases of salmonellosis (two confirmed S. Enteritidis) in young children residing in the Somme department revealed that all cases frequented the same food bank A. Further epidemiological, microbiological and food trace-back investigations indicated frozen beefburgers as the source of the outbreak and the suspected lot originating from Poland was recalled on 22 January 2015. On 2 March 2015 a second notification of S. Enteritidis cases in the Somme reinitiated investigations that confirmed a link with food bank A and with consumption of frozen beefburgers from the same Polish producer. In the face of a possible persistent source of contamination, all frozen beefburgers distributed by food bank A and from the same origin were blocked on 3 March 2015. Microbiological analyses confirmed contamination by S. Enteritidis of frozen beefburgers from a second lot remaining in cases' homes. A second recall was initiated on 6 March 2015 and all frozen beefburgers from the Polish producer remain blocked after analyses identified additional contaminated lots over several months of production.
Subject(s)
Disease Outbreaks , Food Contamination/analysis , Red Meat/microbiology , Salmonella Food Poisoning/epidemiology , Salmonella Infections/epidemiology , Salmonella enteritidis/isolation & purification , Animals , Bacterial Typing Techniques , Child , Child, Preschool , Electrophoresis, Gel, Pulsed-Field , France/epidemiology , Gastroenteritis/epidemiology , Gastroenteritis/etiology , Humans , Male , Poland , Salmonella Food Poisoning/microbiology , Salmonella enteritidis/classificationABSTRACT
The XXXIIIrd Paris Summer Olympics followed by the XVIIth Paralympics Games will take place in France, predominantly in and around Paris, from July 26 to September 8, 2024. Public health stakeholders and decision-makers are called upon to set up or strengthen surveillance systems in areas hosting Olympic or Paralympic Games (OPGs) or large-scale international competitions, the objective being to detect and manage outbreaks should they occur during that period. We undertook a narrative review of the literature so as to identify major reported infectious disease outbreaks linked with or during OPGs / international sporting events during warm seasons. Our review found that since 1992, Summer Olympic and Paralympic games and international football competitions have been associated with sporadic cases of infectious diseases, principally respiratory, gastrointestinal/foodborne, but not with any major communicable or other infectious disease outbreak. Communicable disease risks should be assessed for the population taken as a whole, an integrated ecosystem with several population compartments potentially exchanging pathogens among one another. Although the Games afford an opportunity to federate or invent new surveillance systems to fill a gap, surveillance should be based on existing medical and laboratory systems, proven tools reinforced with the necessary human and financial resources. The performance of the public health surveillance system is ultimately predicated on trust on the part of participating clinicians, policymakers and international partners.
Subject(s)
Communicable Diseases , Disease Outbreaks , Seasons , Sports , Humans , Communicable Diseases/epidemiology , Public Health/methods , Epidemiological MonitoringABSTRACT
BACKGROUND: Cardiogenic dysfunction with acute renal failure (ARF) and diuretic drug resistance increases mortality after cardiac surgery with cardiopulmonary bypass (CPB) in adults. Until few years ago, intermittent renal replacement therapy (IRRT) was the only therapeutical strategy proposed to such patients. Few data are available in the literature regarding the use of continuous veno-venous haemofiltration (CVVH) in this clinical context. The aim of our observational study was to evaluate the impact of CVVH strategy on ARF in conjunction with cardiogenic shock after cardiac surgery and on its well-known associated poor outcome. METHODS: During the period 2005-2006, we prospectively collected data from our database as we controlled the renal replacement therapy using CVVH (n=73). We also retrospectively collected data from our computerised database on patients who were treated with IRRT (n=68, period 2002-2003). Among CVVH-treated patients, a multivariate analysis of the data aimed to identify risk factors associated with 30-day mortality. RESULTS: In patients who presented with ARF in conjunction with cardiogenic shock after cardiac surgery, 30-day mortality rate was 59% for the IRRT group and 42% for the CVVH group. Within the CVVH group, the logistic regression and multivariate analyses reported that some variables were associated with higher mortality risk: a score F concerning the urinary output criteria of the RIFLE (risk, injury, failure, loss, end-stage kidney disease) classification (for scores R or I: odds ratio (OR): 0.01, 95% confidence interval (95% CI): 0.02-0.59; p=0.01), plasma bilirubin (OR: 1.44, 95% CI: 1.12-1.84; p=0.04), total CVVH duration <50h over 72 h (>50h; OR: 0.009, 95% CI: 0.04-0.93; p=0.01), the need of catecholamine support (OR: 12.88, 95% CI: 1.95-84.96; p=0.01), tachycardia in the intensive care unit (ICU; OR: 1.64, 95% CI: 1.02-2.65; p=0.04), surgery duration (<300 min; OR: 0.11, 95% CI: 0.02-0.71; p=0.02) and combined cardiac surgery (OR: 7.00, 95% CI: 1.29-37.88; p=0.02). CONCLUSION: In patients with ARF in conjunction with cardiogenic shock after cardiac surgery, renal replacement therapeutic strategy based on long-lasting CVVH could improve patients' outcome. The identification of risk factors associated with a poor outcome would help to better manage such patients in the ICU. Low total duration of CVVH within the first 72 h was one criteria related to poor outcome. This suggests that CVVH must be initiated as soon as possible when ARF with diuretic resistance occurs in patients after cardiac surgery and continued as long as possible for the first 3 days.